Skip to main content
Top
Published in: Rheumatology International 9/2010

01-07-2010 | Original Article

Diffusion-weighted MR imaging of kidneys in patients with systemic lupus erythematosus: initial experience

Authors: Elif Karadeli, Esra Meltem Kayahan Ulu, Erkan Yildirim, Sema Yilmaz

Published in: Rheumatology International | Issue 9/2010

Login to get access

Abstract

To evaluate kidney perfusion and diffusion in patients with systemic lupus erythematosus (SLE) and define any correlation between laboratory features of renal involvement and apparent diffusion coefficients (ADCs). We studied 35 patients with SLE and 30 healthy volunteers. Ten of the patients were diagnosed as having lupus nephritis. Transverse diffusion-weighted multisection echo-planar magnetic resonance imaging was created with the following diffusion gradient b values: 0, 111, 222, 333, 444, 556, 667, 778, 889, and 1,000 s/mm2. Statistical analyses to compare ADCs of kidneys between patients in the study and control groups were done with the independent sample t test. The Pearson correlation analysis was used to evaluate the relation between the renal function variables and the ADCs. There was statistically significant difference between the ADClow values and the urine protein levels (P < 0.05) in the patients with SLE. Also, there was a significant correlation between the duration of nephritis and urine protein levels in the patients with SLE (P < 0.01). There was no statistically significant differences regarding ADCs, serum creatinine levels, and GFRs among patients with SLE and controls. Our patients had mild SLE and this might be the reason that no statistically significant differences were found between ADCs, and laboratory features of renal involvement among patients with SLE and controls. Larger series and more diffusion experience may be valuable for future studies.
Literature
1.
go back to reference Hahn BH (1993) Management of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th edn. WB Saunders, Philadelphia, pp 1043–1049 Hahn BH (1993) Management of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th edn. WB Saunders, Philadelphia, pp 1043–1049
2.
go back to reference Schoenberg SO, Rieger JR, Michaely HJ, Rupprecht H, Samtleben W, Reiser MF (2006) Functional magnetic resonance imaging in renal artery stenosis. Abdom Imaging. 31(2):200–212CrossRefPubMed Schoenberg SO, Rieger JR, Michaely HJ, Rupprecht H, Samtleben W, Reiser MF (2006) Functional magnetic resonance imaging in renal artery stenosis. Abdom Imaging. 31(2):200–212CrossRefPubMed
3.
go back to reference Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505PubMed Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505PubMed
4.
go back to reference Thoeny HC, De Keyzer F, Oyen RH, Peeters RR (2005) Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 235(3):911–917CrossRefPubMed Thoeny HC, De Keyzer F, Oyen RH, Peeters RR (2005) Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 235(3):911–917CrossRefPubMed
5.
go back to reference Lefkowith JB, Gilkeson GS (1996) Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 39(6):894–903CrossRefPubMed Lefkowith JB, Gilkeson GS (1996) Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 39(6):894–903CrossRefPubMed
6.
go back to reference Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86(7):447–458PubMed Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86(7):447–458PubMed
7.
go back to reference Fukuda Y, Ohashi I, Hanafusa K, Nakagawa T, Ohtani S, An-naka Y, Hayashi T, Shibuya H (2000) Anisotropic diffusion in kidney: apparent diffusion coefficient measurements for clinical use. J Magn Reson Imaging 11(2):156–160CrossRefPubMed Fukuda Y, Ohashi I, Hanafusa K, Nakagawa T, Ohtani S, An-naka Y, Hayashi T, Shibuya H (2000) Anisotropic diffusion in kidney: apparent diffusion coefficient measurements for clinical use. J Magn Reson Imaging 11(2):156–160CrossRefPubMed
8.
go back to reference Müller MF, Prasad PV, Bimmler D, Kaiser A, Edelman RR (1994) Functional imaging of the kidney by means of measurement of the apparent diffusion coefficient. Radiology 193(3):711–715PubMed Müller MF, Prasad PV, Bimmler D, Kaiser A, Edelman RR (1994) Functional imaging of the kidney by means of measurement of the apparent diffusion coefficient. Radiology 193(3):711–715PubMed
9.
go back to reference Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Tang Y, Takahashi M (1999) Measurement of the apparent diffusion coefficient in diffuse renal disease by diffusion-weighted echo-planar MR imaging. J Magn Reson Imaging 9(6):832–837CrossRefPubMed Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Tang Y, Takahashi M (1999) Measurement of the apparent diffusion coefficient in diffuse renal disease by diffusion-weighted echo-planar MR imaging. J Magn Reson Imaging 9(6):832–837CrossRefPubMed
10.
go back to reference Yildirim E, Kirbas I, Teksam M, Karadeli E, Gullu H, Ozer I (2008) Diffusion-weighted MR imaging of kidneys in renal artery stenosis. Eur J Radiol 65(1):148–153CrossRefPubMed Yildirim E, Kirbas I, Teksam M, Karadeli E, Gullu H, Ozer I (2008) Diffusion-weighted MR imaging of kidneys in renal artery stenosis. Eur J Radiol 65(1):148–153CrossRefPubMed
11.
go back to reference Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G (2004) Clinical practice guidelines for chronic kidney disease in adults: part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician 70(5):869–876PubMed Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G (2004) Clinical practice guidelines for chronic kidney disease in adults: part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician 70(5):869–876PubMed
12.
go back to reference National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(21):S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(21):S1–S266
Metadata
Title
Diffusion-weighted MR imaging of kidneys in patients with systemic lupus erythematosus: initial experience
Authors
Elif Karadeli
Esra Meltem Kayahan Ulu
Erkan Yildirim
Sema Yilmaz
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1124-z

Other articles of this Issue 9/2010

Rheumatology International 9/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.